These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Reduction by propranolol of hypertension induced by dephrenation in the dog]. Basset A, Besombes JP, Montastruc P, Vanche J. C R Seances Soc Biol Fil; 1973; 167(1):152-5. PubMed ID: 4804692 [No Abstract] [Full Text] [Related]
23. [Is energetic-dynamic heart failure only a syndrome?]. Hegglin R, Turina M, Krayenbühl HP. Schweiz Med Wochenschr; 1969 May 10; 99(19):693-8. PubMed ID: 5785436 [No Abstract] [Full Text] [Related]
24. Cardiovascular properties of a new cardiotonic agent, MDL 19205. Dage RC, Roebel LE, Hsieh CP, Woodward JK. J Cardiovasc Pharmacol; 1984 May 10; 6(1):35-42. PubMed ID: 6199609 [Abstract] [Full Text] [Related]
30. Left ventricular function in man following thiopental. Dwyer EM, Wiener L. Anesth Analg; 1969 Jan 10; 48(3):499-505. PubMed ID: 5815113 [No Abstract] [Full Text] [Related]
31. Effect of beta-adrenergic blockade on left ventricular function in exercise. Horwitz LD, Atkins JM, Leshin SJ. Am J Physiol; 1974 Oct 10; 227(4):839-42. PubMed ID: 4429132 [No Abstract] [Full Text] [Related]
37. The effect of propranolol on circulatory hemodynamics of patients with coronary heart failure in the light of polycardiographic examination. Mazurowa A, Tracz W. Pol Med J; 1970 Oct 10; 9(4):827-34. PubMed ID: 5477489 [No Abstract] [Full Text] [Related]
40. The effects of bufuralol, a beta-adrenoceptor antagonist with predominant beta 2-adrenoceptor agonistic activity, in the cat and the dog. Blaber LC, Burden DT, Eigenmann R, Gerold M. J Cardiovasc Pharmacol; 1984 Oct 10; 6(1):165-75. PubMed ID: 6199600 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]